Ovoca Bio Statistics

Total Valuation

Ovoca Bio has a market cap or net worth of GBP 937,984. The enterprise value is -1.54 million.

Market Cap	937,984
Enterprise Value	-1.54M

Important Dates

The next estimated earnings date is Wednesday, June 25, 2025.

Earnings Date	Jun 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Ovoca Bio has 81.56 million shares outstanding. The number of shares has increased by 6.93% in one year.

Current Share Class	81.56M
Shares Outstanding	81.56M
Shares Change (YoY)	+6.93%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.18%
Owned by Institutions (%)	n/a
Float	52.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	2.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.59

Current Ratio	3.59
Quick Ratio	3.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	265.94

Financial Efficiency

Return on equity (ROE) is -108.96% and return on invested capital (ROIC) is 4.56%.

Return on Equity (ROE)	-108.96%
Return on Assets (ROA)	3.70%
Return on Invested Capital (ROIC)	4.56%
Return on Capital Employed (ROCE)	11.89%
Revenue Per Employee	n/a
Profits Per Employee	-605,852
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.78% in the last 52 weeks. The beta is 0.63, so Ovoca Bio's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+27.78%
50-Day Moving Average	0.83
200-Day Moving Average	1.24
Relative Strength Index (RSI)	0.85
Average Volume (20 Days)	8,666

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	225,520
Pretax Income	-3.37M
Net Income	-3.03M
EBITDA	504,453
EBIT	225,520
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 2.48 million in cash and n/a in debt, giving a net cash position of 2.48 million or 0.03 per share.

Cash & Cash Equivalents	2.48M
Total Debt	n/a
Net Cash	2.48M
Net Cash Per Share	0.03
Equity (Book Value)	1.90M
Book Value Per Share	0.02
Working Capital	1.90M

Full Balance Sheet

Cash Flow

Operating Cash Flow	342,519
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ovoca Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.93%
Shareholder Yield	n/a
Earnings Yield	-322.95%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 18, 2010. It was a reverse split with a ratio of 0.2.

Last Split Date	Jan 18, 2010
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	3